| First Author | Kulkarni RN | Year | 1997 |
| Journal | J Clin Invest | Volume | 100 |
| Issue | 11 | Pages | 2729-36 |
| PubMed ID | 9389736 | Mgi Jnum | J:45259 |
| Mgi Id | MGI:1194705 | Doi | 10.1172/JCI119818 |
| Citation | Kulkarni RN, et al. (1997) Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 100(11):2729-36 |
| abstractText | Obesity is associated with diabetes, and leptin is known to be elevated in obesity. To investigate whether leptin has a direct effect on insulin secretion, isolated rat and human islets and cultured insulinoma cells were studied, In all cases, mouse leptin inhibited insulin secretion at concentrations within the plasma range reported in humans, Insulin mRNA expression was also suppressed in the cultured cells and rat islets. The long form of the leptin receptor (OB-Rb) mRNA was present in the islets and insulinoma cell lines. To determine the significance of these findings in vivo, normal fed mice were injected with two doses of leptin. A significant decrease in plasma insulin and associated rise in glucose concentration were observed. Fasted normal and leptin receptor-deficient db/db mice showed no response to leptin. A dose of leptin, which mimicked that found in normal mice, was administered to leptin-deficient, hyperinsulinemic ob/ob mice, This caused a marked lowering of plasma insulin concentration and a doubling of plasma glucose. Thus, leptin has a powerful acute inhibitory effect on insulin secretion, These results suggest that the action of leptin may be one mechanism by which excess adipose tissue could acutely impair carbohydrate metabolism. |
